MetaCap

AZZ (AZZ) vs Enovis (ENOV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

AZZ (AZZ) has outperformed Enovis (ENOV) over the past year, gaining 14.3% versus a loss of 11.5%. Over five years, AZZ leads with a +121.2% price change compared with -69.5% for ENOV. AZZ is the larger company by market cap ($3.51 billion vs $1.47 billion), about 2.4 times the size, while Enovis is growing revenue faster (+6.7% vs +4.6%).

On valuation, Enovis trades at a lower forward P/E (7.4x vs 14.8x for AZZ). AZZ pays a dividend yielding 0.72%, while Enovis does not currently pay one. AZZ converts more of its revenue into profit, with a net margin of 19.2% versus -52.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AZZ+14.26%ENOV-11.47%
+61%+8%-44%
Nov 21, 20251 yearNov 20, 2026
AZZ+110.38%ENOV-70.68%
+195%+51%-93%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AZZ versus ENOV key metrics
MetricAZZENOV
Share price$117.37$25.47
Market cap$3.51B$1.47B
1-day change-4.58%-2.90%
YTD return+9.51%-4.39%
1-year return+14.26%-11.47%
5-year return+121.24%-69.49%
P/E ratio (TTM)21.15—
Forward P/E14.837.35
EPS (TTM)$5.55$-9.23
Dividend yield0.72%0.00%
Annual dividend$0.84$0.00
Revenue (latest FY)$1.65B$2.25B
Revenue growth (YoY)+4.58%+6.66%
Net income (latest FY)$317.26M$-1.18B
Gross margin23.94%59.84%
Operating margin16.04%-50.01%
Net margin19.23%-52.69%
52-week high$162.20$31.67
52-week low$101.82$16.70
Distance from 52-week high-27.64%-19.58%
Analyst consensusnonestrong_buy
Avg. price target upside+38.28%+48.53%
Average volume242.20K1.71M
Shares outstanding29.92M57.69M
Employees3,7677,802
SectorIndustrialsHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • AZZ is about 2.4 times larger than Enovis by market value ($3.51B vs $1.47B).
  • AZZ has outperformed ENOV by 25.7 percentage points over the past year.
  • AZZ is more profitable, keeping 19.2 cents of every revenue dollar as net income versus -52.7 cents for Enovis.
  • The two companies sit in different sectors: AZZ in Industrials and Enovis in Health Care.

About AZZ

AZZ stock →

AZZ Inc. provides hot-dip galvanizing and coil coating solutions in North America.

Industrials · Industrial Specialties · 3,767 employees

About Enovis

ENOV stock →

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Health Care · Industrial Specialties · 7,802 employees

AZZ vs ENOV FAQ

Which is bigger, AZZ or Enovis?

AZZ (AZZ) is larger, with a market capitalization of $3.51B compared with $1.47B for Enovis (ENOV).

Which stock has performed better over the past year, AZZ or ENOV?

AZZ returned +14.26% over the past 12 months, compared with -11.47% for ENOV (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, AZZ or Enovis?

AZZ pays a dividend yielding 0.72%, while Enovis does not currently pay a regular dividend.

Are AZZ and Enovis in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Industrials sector.

More comparisons